Abstract:ObjectivesPreprotein convertase 1/3 deficiency is a rare autosomal recessive disorder in which patients present with malabsorptive diarrhea and a series of symptoms of endocrine disorders such as polydipsia, reactive hypoglycemia, growth hormone deficiency, hypothyroidism, adrenal insufficiency, and early onset obesity. In its essence, pituitary hormone deficiency is caused by insufficient cleavage of pituitary prohormones. Here, we describe a female child with a rare double-site homozygous mutation in PCSK1 (Proprotein convertase subtilisin/kexin-type 1) gene, and thereby intend to investigate the relationship between these novel mutation sites and changes in protein synthesis and function.MethodsWe tested this patient's blood and urine fecal indicators of infection, blood electrolytes, and relevant endocrine hormone levels in the laboratory. Next Generation Sequencing was applied to screen the patient's DNA. Western Blot was performed to evaluate the mutant protein's expression. The enzymatic activity was measured as the rate of cleavage of a synthetic fluorogenic substrate in a specific solution.ResultsWe found that this patient presented shortly after birth with uncorrectable diarrhea and symptoms of metabolic acidosis with hypothyroidism. Next Generation Sequencing revealed that a rare double-site homozygous missense mutation, c.763G > A (p.G255R) and c.758C > T (p.S253L), were detected in exon 7 of PCSK1 (Proprotein convertase subtilisin/kexin-type 1) gene on chromosome 5 of the patient. Western blotting revealed that there was no significant decrease in protein synthesis levels in the mutant phenotype compared to the wild type. Compared with WT type, the proteins expressed by the mutations showed a significant decrease in the enzyme activity towards the fluorescent substrates. However, neither the single site mutation p.S253L or p.G255R, nor the double-site mutation of both, all showed no significant differences from each other.ConclusionsThese two missense mutations have not been reported before, and it is even rarer to find homozygous variation of two sites in one patient. This study identifies two novel mutations for the first time and further investigates the changes in protein synthesis and enzyme activity, providing a new pathway to continue to explore the pathogenesis of diseases associated with the function of PC1/3.

Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion

A large deletion of PROP1 gene in patients with combined pituitary hormone deficiency from two unrelated Chinese pedigrees.

Comparison of clinical characteristics of a pediatric cohort with combined pituitary hormone deficiency caused by mutation of the PROP1 gene or of other origins

Childhood Combined Pituitary Hormone Deficiency

[Clinical and Genetic Characteristics of a Young Child with Combined Pituitary Hormone Deficiency Type I Caused by POU1F1 Gene Variation].

Long-term Follow-Up of Children with Carbamoyl Phosphate Synthase 1 Deficiency Detected in Newborn Screening.

A Novel Compound Heterozygous CYP17A1 Variant Causes 17α-Hydroxylase/17, 20-Lyase Deficiency.

X-linked Recessive Combined Pituitary Hormone Deficiency is Mapped to Xp22.3–Xp11 in a Chinese Family

Clinical and Genetic Analysis of an Infant with Combined Pituitary Hormone Deficiency Due to POU1F1 Gene Variants

Etiology of combined pituitary hormone deficiency: GNAO1 as a novel candidate gene

A Novel Splice-Site Deletion in the POU1F1 Gene Causes Combined Pituitary Hormone Deficiency in Multiple Sudanese Pedigrees

Gene Misexpression in a Smoc2+ve/ Sox2-Low Population in Juvenile Prop1-Mutant Pituitary Gland

Modulation of PC1/3 activity by a rare double-site homozygous mutation

Congenital Hypopituitarism Due to Novel Compound Heterozygous POU1F1 Gene Mutation: A Case Report and Review of the Literature

Growth Hormone Deficiency with Advanced Bone Age: Phenotypic Interaction Between GHRH Receptor and CYP21A2 Mutations Diagnosed by Sanger and Whole Exome Sequencing

Comparative genomics reveals functional transcriptional control sequences in the Prop1 gene

Clinical and Biochemical Consequences of an Intragenic Growth Hormone Receptor (GHR) Deletion in a Large Chinese Pedigree

Allelic Variants in Established Hypopituitarism Genes Expand Our Knowledge of the Phenotypic Spectrum

Digenic Congenital Hypogonadotropic Hypogonadism Due to Heterozygous GNRH1 p.R31C and AMHR2 p.G445_L453del Variants

Isolated Growth Hormone (gh) Deficiency Due to Compound Heterozygosity for Two New Mutations in the Gh-Releasing Hormone Receptor Gene

Concurrent mutations of germline GPR101 and somatic USP8 in a pediatric giant pituitary ACTH adenoma: a case report